Several techniques exist that permit the efficient distinction among characterized DNA sequence variants. In this review we discuss a number of such analytic procedures. These techniques all take advantage of a variety solid supports to prepare and analyze reaction products. The described diagnostic
Mutation detection by solid phase primer extension
β Scribed by John M. Shumaker; Andres Metspalu; C. Thomas Caskey
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 856 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
β¦ Synopsis
A mutation analysis method based upon a wild-type DNA sequence is presented. Oligonucleotides were utilized for primer extension by T7 DNA polymerase to discriminate between wild-type and mutant sequences in two solid phase approaches. 1. Oligonucleotides were annealed to an immobilized template, extended with fluorescent dideoxynucleotides (ddNTPs), and analyzed on an automated fluorescent DNA sequencer. The oligonucleotide length identified the known mutation site, and the fluorescence emission of the ddNTP identified the mutation. 2. Template DNA was annealed to an oligonucleotide array, extended with CY-~'P dNTPs, and analyzed with a Phosphor Imager. The grid position of the oligonucleotide identified the mutation site and the extended base identified the mutation. 0 1 9 % WiIey-Lus, Inc.
π SIMILAR VOLUMES
We have developed a solid phase chemical cleavage method (SpCCM) for screening large DNA fragments for mutations. All reactions can be carried out in microtiterwells from the first amplification of the patient (or test) DNA through the search for mutations. The reaction time is significantly reduced
## Communicated by Peter Oefner Beta-thalassemia is a common inherited disease, resulting from one or more of a total of more than 200 different mutations in the b-globin gene (HBB). Efficient and reliable mutation-screening methods are essential in order to establish appropriate prevention program
## Abstract Mutations in the __KRAS__ gene are very important diagnostic and prognostic markers in cancer. Particularly, __KRAS__ mutations at codons 12 and 13 have a high prognostic value for EGFRβdirected antibody therapies. Several methods are available to detect the most common mutations, some